Related Experiment Video

Updated: Jun 1, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
10:50

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Published on: April 24, 2021

CSN1 inhibits c-Jun phosphorylation and down-regulates ectopic expression of JNK1

Tomohiko Tsuge1, Suchithra Menon, Yingchun Tong

  • 1Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, 06520, USA. tsuge@scl.kyoto-u.ac.jp

Protein & Cell
|May 24, 2011
PubMed

Insights

COP9 signalosome subunit 1 (CSN1) negatively regulates the activator protein 1 (AP-1) pathway by inhibiting c-Jun phosphorylation and JNK1 expression. This study reveals CSN1

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Protein Regulation

Background:

  • The COP9 signalosome (CSN) is a crucial protein complex regulating diverse cellular processes.
  • CSN influences ubiquitin-proteasome dependent degradation through deneddylation and deubiquitination.
  • CSN modulates cell signaling pathways, including the activator protein 1 (AP-1) pathway.

Purpose of the Study:

  • To investigate the role of CSN1 in regulating the AP-1 pathway.
  • To elucidate the mechanisms by which CSN1 affects AP-1 transcription factors and signaling.

Main Methods:

  • Investigated CSN1's effect on c-Jun phosphorylation and transcription activity.
  • Analyzed CSN1's impact on c-Jun N-terminal kinase 1 (JNK1) expression.
  • Examined transcriptional and post-transcriptional regulatory mechanisms involved.

Main Results:

  • CSN1 inhibits c-Jun phosphorylation and represses c-Jun dependent transcription.
  • CSN1 significantly downregulates ectopic JNK1 expression.
  • The downregulation of JNK1 by CSN1 is independent of proteolysis and mRNA instability, suggesting transcriptional or post-transcriptional control.

Conclusions:

  • CSN1 acts as a negative regulator of the AP-1 pathway, contrasting with CSN5/Jab1.
  • CSN1 influences AP-1 activity through repression of key signaling components like JNK1.
  • The dynamic equilibrium of CSN complexes plays a role in regulating the AP-1 pathway.

More Related Videos

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting10:08

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...